His medical history included only obesity, which was the reason for initiating semaglutide (Wegovy) therapy eight months earlier
Data extraction Two designated authors (AM and SS) meticulously extracted pertinent data from the included studies, including authorship details, publication timeline, samples of the study, mean demographic parameters (e.g., age, sex, baseline weight, and baseline BMI), type of bariatric surgery, prevalent background diseases, type of the GLP-1RAs therapy, the time of the initiation of the medical treatment, laboratory indices, amount of weight-change, and a comprehensive array of outcome measures, such as nausea, vomiting, diarrhea, and serious adverse events
Experience the transformative power of Dihexa and unlock a world of cognitive vitality and well-being
Risk Factors That May Increase Heartburn on Semaglutide Patients with a pre-existing history of gastroesophageal reflux disease (GERD) or sensitive stomachs are more likely to experience heartburn during semaglutide treatment
Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons
